Dafalgan DOLO 500 mg, Brausetabletten
7680692650016
CH-69265
Brausetabletten
Associated product:
DAFALGAN DOLO cpr eff 500 mg 16 pce
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 16
- Selling units
- 16
- Measure
- Tablette(n)
- Galenic form
- Brausetabletten
- Galenic group
- Brausetabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
paracetamolum
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
acidum citricum
|
- | Substance | HNIDK |
|
natrii hydrogenocarbonas
|
- | Substance | HNIDK |
|
natrii carbonas
|
- | Substance | HNIDK |
|
sorbitolum
|
126.1 MG | Substance | HBESI |
|
E 211
|
50.0 MG | Substance | HBESI |
|
aromatica
|
- | Substance | AROMA |
|
glucosum
|
0.83 MG | Substance | HBESI |
|
fructosum
|
0.96 MG | Substance | HBESI |
|
saccharum
|
0.28 MG | Substance | HBESI |
|
saccharinum natricum
|
- | Substance | HIMDK |
|
povidonum K 30
|
- | Substance | HNIDK |
|
natrii docusas
|
- | Substance | HNIDK |
|
natrium
|
197.0 MG | Substance | HBESI |
Authorization holder
UPSA Switzerland AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 69265
- Drug name
- Dafalgan DOLO, Brausetabletten
- Galenic form
- BRAT
- ATC Code
- N02BE01
- Authorization status
- Z
- Dispensing category
- D
- First authorization
- 01/05/2024
- Authorization expiration date
- 30/04/2029
- IT Number
- 01.01.1.
- Domain
- Human medicine
Package details
- Description (FR)
- DAFALGAN DOLO cpr eff 500 mg 16 pce
- Description (DE)
- DAFALGAN DOLO Brausetabl 500 mg 16 Stk
- Market launch
- 25/11/2024
- Narcotic (BTM)
- No